In this regard, Prendecki et al. 2019 [5] highlighted that plasma levels of miR-107 and miR-650 in AD patients, quantified by quantitative PCR (qPCR), may be related to APOE genetic variants and clinical characteristics, including the age of onset and severity of dementia. This evidence concerns the gene APOE and Alzheimer disease.